Miromatrix Medical Inc.
MIRODelisted Dec 13, 2023- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001527096
Miromatrix Medical Inc. was delisted on Dec 13, 2023; its insiders filed their last Form 4 on Dec 13, 2023; 32 institutions reported holding it in 13F filings for Q3 2023, worth $8.78M in total; no superinvestor held it.
Q4 2022 vs. Q3 2022
How the institutions holding Miromatrix Medical Inc. changed between Q3 2022 and Q4 2022.
All holders in Q4 2022All holders in Q3 2022
| Measure | Q3 2022 | Q4 2022 | Change |
|---|---|---|---|
| Holders | 22 | 28 | +6 |
| Shares | 3.52M | 3.75M | +223.9K (+6.4%) |
| Value | $15.4M | $11.2M | −$4.23M (−27.4%) |
New holders (7)
Institutions that held Miromatrix Medical Inc. at the end of Q4 2022 but not at the end of Q3 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Mayo Clinic | 191,622 | $573.0K | 0.30% |
| Merit Financial Group, LLC | 60,900 | $182.1K | 0.01% |
| Susquehanna International Group, LLP | 19,739 | $59.0K | 0.00% |
| HHM Wealth Advisors, LLC | 3,500 | $10.5K | 0.00% |
| JPMorgan Chase & Co | 1,645 | $5.00K | 0.00% |
| Harbour Investments, Inc. | 38 | $114 | 0.00% |
| Bank of America Corp | 32 | $96 | 0.00% |
Sold out (1)
Institutions that held Miromatrix Medical Inc. at the end of Q3 2022 and filed for Q4 2022 without it.
| Institution | Shares, Q3 2022 | Value, Q3 2022 |
|---|---|---|
| UBS Group AG | 3,964 | $17.0K |